These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 2995571)
1. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine. Kayser M; Klein H; Paasch I; Pilaski J; Blenk H; Heeg K J Med Virol; 1985 Sep; 17(1):35-45. PubMed ID: 2995571 [TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity in flavivirus serology: new implications of an old finding? Allwinn R; Doerr HW; Emmerich P; Schmitz H; Preiser W Med Microbiol Immunol; 2002 Mar; 190(4):199-202. PubMed ID: 12005333 [TBL] [Abstract][Full Text] [Related]
3. Antigenic comparison of envelope protein E between Japanese encephalitis virus and some other flaviviruses using monoclonal antibodies. Kimura-Kuroda J; Yasui K J Gen Virol; 1986 Dec; 67 ( Pt 12)():2663-72. PubMed ID: 2432163 [TBL] [Abstract][Full Text] [Related]
4. Flavivirus-induced antibody cross-reactivity. Mansfield KL; Horton DL; Johnson N; Li L; Barrett ADT; Smith DJ; Galbraith SE; Solomon T; Fooks AR J Gen Virol; 2011 Dec; 92(Pt 12):2821-2829. PubMed ID: 21900425 [TBL] [Abstract][Full Text] [Related]
5. Effect of previous heterologous flavivirus vaccinations on human antibody responses in tick-borne encephalitis and dengue virus infections. Roßbacher L; Malafa S; Huber K; Thaler M; Aberle SW; Aberle JH; Heinz FX; Stiasny K J Med Virol; 2023 Nov; 95(11):e29245. PubMed ID: 38009693 [TBL] [Abstract][Full Text] [Related]
7. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584 [TBL] [Abstract][Full Text] [Related]
8. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585 [TBL] [Abstract][Full Text] [Related]
9. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis. Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis. Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679 [TBL] [Abstract][Full Text] [Related]
11. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Lai CJ; Monath TP Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441 [TBL] [Abstract][Full Text] [Related]
12. Correlation between ELISA, hemagglutination inhibition, and neutralization tests after vaccination against tick-borne encephalitis. Holzmann H; Kundi M; Stiasny K; Clement J; McKenna P; Kunz C; Heinz FX J Med Virol; 1996 Jan; 48(1):102-7. PubMed ID: 8825718 [TBL] [Abstract][Full Text] [Related]
13. Diagnosis of tick-borne encephalitis: evaluation of sera with borderline titers with the TBE-ELISA. Dobler G; Treib J; Kiessig ST; Blohn WV; Frösner G; Haass A Infection; 1996; 24(5):405-6. PubMed ID: 8923059 [TBL] [Abstract][Full Text] [Related]
15. Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen. Tsouchnikas G; Zlatkovic J; Jarmer J; Strauß J; Vratskikh O; Kundi M; Stiasny K; Heinz FX J Virol; 2015 Aug; 89(15):7970-8. PubMed ID: 26018152 [TBL] [Abstract][Full Text] [Related]
16. Single-dose vaccine against tick-borne encephalitis. Rumyantsev AA; Goncalvez AP; Giel-Moloney M; Catalan J; Liu Y; Gao QS; Almond J; Kleanthous H; Pugachev KV Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13103-8. PubMed ID: 23858441 [TBL] [Abstract][Full Text] [Related]
17. Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination. Jarmer J; Zlatkovic J; Tsouchnikas G; Vratskikh O; Strauß J; Aberle JH; Chmelik V; Kundi M; Stiasny K; Heinz FX J Virol; 2014 Dec; 88(23):13845-57. PubMed ID: 25253341 [TBL] [Abstract][Full Text] [Related]
18. Heterologous flavivirus infection-enhancing antibodies in sera of Nigerians. Fagbami A; Halstead SB; Marchette N; Larsen K Am J Trop Med Hyg; 1988 Jan; 38(1):205-7. PubMed ID: 2829637 [TBL] [Abstract][Full Text] [Related]
19. Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Kanesa-Thasan N; Putnak JR; Mangiafico JA; Saluzzo JE; Ludwig GV Am J Trop Med Hyg; 2002 Feb; 66(2):115-6. PubMed ID: 12135278 [TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis vaccine-facilitated dengue virus infection-enhancement antibody in adults. Saito Y; Moi ML; Takeshita N; Lim CK; Shiba H; Hosono K; Saijo M; Kurane I; Takasaki T BMC Infect Dis; 2016 Oct; 16(1):578. PubMed ID: 27756212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]